Real-Time fMRI Helps Treat Tourette Syndrome
By MedImaging International staff writers Posted on 12 Sep 2019 |
Image: Research shows fMRI neurofeedback could offer a potential treatment for TS (Photo courtesy of Yale University).
Adolescents with Tourette Syndrome (TS) can control their facial tics through an imaging technique that allows them to monitor the function of their own brain in real time.
Researchers at Yale School of Medicine (New Haven, CT, USA) conducted a randomized, sham-controlled trial in 21 adolescents with TS to examine if real-time functional magnetic resonance imaging (fMRI) neurofeedback could help reduce activity in the supplementary motor area (SMA), which has been shown to be responsible for TS tics. The primary outcome measure of tic severity was the Yale Global Tic Symptom Severity Scale (YGTSS), with the secondary outcome being control over the SMA, as assessed in neuroimaging scans.
The study subjects were tasked with alternately raising and lowering activity in the SMA, which was displayed as a real-time graph during brain imaging scans. The results showed that participants had a significant 3.8-point difference in tic reduction on the YGTSS scale after neurofeedback, as compared to sham. However, there were no differences in changes on the secondary measure of control over the SMA. The study was published on August 13, 2019, in the Journal of Biological Psychiatry.
“Currently available treatments for tics in Tourette Syndrome include behavior therapy and pharmaceuticals, but not everyone responds. This is the first study of its kind showing that real-time fMRI neurofeedback has potential as a treatment,” said lead author Denis Sukhodolsky, PhD, of the Yale Child Study Center. “However, no effects were found in terms of change in control over the SMA, the hypothesized mechanism of action.”
TS is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The disorder is named after Dr. Georges Gilles de la Tourette, the pioneering French neurologist who in 1885 first described the condition in an 86-year-old French noblewoman. The early symptoms are typically noticed first in childhood, with average onset between the ages of three and nine. Although TS symptoms may last a lifetime, most people with the condition experience their worst tic symptoms in their early teens, with improvement occurring in the late teens and continuing into adulthood.
Related Links:
Yale School of Medicine
Researchers at Yale School of Medicine (New Haven, CT, USA) conducted a randomized, sham-controlled trial in 21 adolescents with TS to examine if real-time functional magnetic resonance imaging (fMRI) neurofeedback could help reduce activity in the supplementary motor area (SMA), which has been shown to be responsible for TS tics. The primary outcome measure of tic severity was the Yale Global Tic Symptom Severity Scale (YGTSS), with the secondary outcome being control over the SMA, as assessed in neuroimaging scans.
The study subjects were tasked with alternately raising and lowering activity in the SMA, which was displayed as a real-time graph during brain imaging scans. The results showed that participants had a significant 3.8-point difference in tic reduction on the YGTSS scale after neurofeedback, as compared to sham. However, there were no differences in changes on the secondary measure of control over the SMA. The study was published on August 13, 2019, in the Journal of Biological Psychiatry.
“Currently available treatments for tics in Tourette Syndrome include behavior therapy and pharmaceuticals, but not everyone responds. This is the first study of its kind showing that real-time fMRI neurofeedback has potential as a treatment,” said lead author Denis Sukhodolsky, PhD, of the Yale Child Study Center. “However, no effects were found in terms of change in control over the SMA, the hypothesized mechanism of action.”
TS is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The disorder is named after Dr. Georges Gilles de la Tourette, the pioneering French neurologist who in 1885 first described the condition in an 86-year-old French noblewoman. The early symptoms are typically noticed first in childhood, with average onset between the ages of three and nine. Although TS symptoms may last a lifetime, most people with the condition experience their worst tic symptoms in their early teens, with improvement occurring in the late teens and continuing into adulthood.
Related Links:
Yale School of Medicine
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs